European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

[1]  F. Aberra.  Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease. , 2009, Gastroenterology.

[2]  P. Ferenci,et al.  Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C , 2008, Alimentary pharmacology & therapeutics.

[3]  I. Stephenson,et al.  Antiviral treatment and prevention of seasonal influenza: a comparative review of recommendations in the European Union. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  H. Ayles,et al.  The Effects of HIV on the Sensitivity of a Whole Blood IFN-γ Release Assay in Zambian Adults with Active Tuberculosis , 2008, PloS one.

[5]  N. Balato,et al.  Performance of two commercial blood IFN-γ release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-α treatment , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  A. Zinsmeister,et al.  Risk factors for opportunistic infections in patients with inflammatory bowel disease. , 2008, Gastroenterology.

[7]  F. Nagy,et al.  Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease. , 2008, Inflammatory bowel diseases.

[8]  S. Kane,et al.  Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease , 2008, The American Journal of Gastroenterology.

[9]  T. Monaghan,et al.  Recent advances in Clostridium difficile-associated disease , 2008, Postgraduate Medical Journal.

[10]  O. Chosidow,et al.  Treatment to prevent recurrent genital herpes , 2008, Current opinion in infectious diseases.

[11]  A. Osterhaus,et al.  Influenza Vaccination Is Efficacious and Safe in Renal Transplant Recipients , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  E. Scherl,et al.  Prophylaxis against Pneumocystis pneumonia in patients with inflammatory bowel disease: Toward a standard of care , 2008, Inflammatory bowel diseases.

[13]  B. Finlay,et al.  Pathogenesis of enteric Salmonella infections , 2008, Current opinion in gastroenterology.

[14]  G. Rimmelzwaan,et al.  The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccination , 2007, Annals of the rheumatic diseases.

[15]  J. Rhodes,et al.  Review article: minimizing tuberculosis during anti‐tumour necrosis factor‐alpha treatment of inflammatory bowel disease , 2007, Alimentary pharmacology & therapeutics.

[16]  P. Villiger,et al.  Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay , 2007, Annals of the rheumatic diseases.

[17]  H. Yamanaka,et al.  Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis , 2007, Annals of the rheumatic diseases.

[18]  J. Gisbert,et al.  Tuberculous chemoprophylaxis requirements and safety in inflammatory bowel disease patients prior to anti‐TNF therapy , 2007, Inflammatory bowel diseases.

[19]  B. Thiers.  American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors , 2008 .

[20]  J. Barkin.  Impact of Clostridium difficile on Inflammatory Bowel Disease , 2008 .

[21]  B. Diederen.  Legionella spp. and Legionnaires' disease. , 2008, The Journal of infection.

[22]  L. Leibovici,et al.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. , 2014, The Cochrane database of systematic reviews.

[23]  M. Vivarelli,et al.  Influence of steroids on HCV recurrence after liver transplantation: A prospective study. , 2007, Journal of hepatology.

[24]  Herbert L DuPont,et al.  The growing threat of foodborne bacterial enteropathogens of animal origin. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  Mahnaz Fatahzadeh,et al.  Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. , 2007, Journal of the American Academy of Dermatology.

[26]  T. Wright,et al.  2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests , 2007, Journal of lower genital tract disease.

[27]  Cecile Viboud,et al.  Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.

[28]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[29]  F. Austin,et al.  Toward an improved laboratory definition of Listeria monocytogenes virulence. , 2007, International journal of food microbiology.

[30]  Jose Jeronimo,et al.  Human papillomavirus and cervical cancer , 2007, The Lancet.

[31]  P. Rutgeerts,et al.  Adalimumab Safety in Crohnʼs Disease Patients: Open-Label Maintenance Following the Gain and CHARM Trials: 1031 , 2007 .

[32]  F. Sitas,et al.  The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV‐16, HPV‐18, and HPV‐11 capsid‐antigens in mothers and their children , 2007, Journal of medical virology.

[33]  T. Walles,et al.  Herpes simplex virus colitis complicating ulcerative colitis: A case report and brief review on superinfections. , 2007, Journal of Crohn's & colitis.

[34]  A. Gasbarrini,et al.  Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up , 2007, Alimentary pharmacology & therapeutics.

[35]  C. Brensinger,et al.  Risk for active tuberculosis in inflammatory bowel disease patients. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[36]  B. Gazzard,et al.  Tuberculosis antigen‐specific immune responses can be detected using enzyme‐linked immunospot technology in human immunodeficiency virus (HIV)‐1 patients with advanced disease , 2007, Clinical and experimental immunology.

[37]  T. Riley,et al.  Clostridium difficile‐associated diarrhoea , 2007, Internal medicine journal.

[38]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  J. Palefsky.  Human papillomavirus infection in HIV-infected persons. , 2007, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[40]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[41]  M. Daperno,et al.  Infliximab and the risk of latent viruses reactivation in active Crohn's disease , 2007, Inflammatory bowel diseases.

[42]  Louis J. Cohen,et al.  Immune response to influenza vaccine in pediatric patients with inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  M. Hudson,et al.  Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. , 2007, Rheumatology.

[44]  Y. Ishigatsubo,et al.  [Tuberculosis associated with anti-TNF therapy]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[45]  D. Cirillo,et al.  Use of T-SPOT.TB in latent tuberculosis infection diagnosis in general and immunosuppressed populations. , 2007, The new microbiologica.

[46]  J. Seward,et al.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[47]  Curtis J Donskey,et al.  Reduction of Clostridium Difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods , 2007, BMC infectious diseases.

[48]  P. Durez,et al.  Listeria infections associated with infliximab: case reports , 2007, Clinical Rheumatology.

[49]  J. Gómez-Reino,et al.  Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. , 2007, Arthritis and rheumatism.

[50]  W. Blonski,et al.  Safety of biologic therapy. , 2007, Inflammatory bowel diseases.

[51]  B. Kampmann,et al.  Evidence for boosting Mycobacterium tuberculosis-specific IFN-γ responses at 6 weeks following tuberculin skin testing , 2007, European Respiratory Journal.

[52]  G. Poland,et al.  Pneumococcal vaccination in adults: recommendations, trends, and prospects. , 2007, Cleveland Clinic journal of medicine.

[53]  K. Imai,et al.  Interferon γ assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration , 2007, Rheumatology International.

[54]  J. Bendell,et al.  Anal cancer: an overview. , 2007, The oncologist.

[55]  A. Levinson,et al.  Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. , 2007, The Journal of rheumatology.

[56]  E. Bouza,et al.  Cryptococcal meningitis in a patient treated with infliximab. , 2007, Diagnostic microbiology and infectious disease.

[57]  J. Ablin,et al.  Safety and efficacy of vaccination against streptococcus pneumonia in patients with rheumatic diseases. , 2007, Autoimmunity reviews.

[58]  M. Cottone,et al.  Occult hepatitis B and infliximab-induced HBV reactivation. , 2007, Inflammatory bowel diseases.

[59]  M. Woodhead,et al.  New guidelines for the management of adult community-acquired pneumonia , 2007, Current opinion in infectious diseases.

[60]  H. Lawson,et al.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[61]  M. Pai,et al.  Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research , 2007, Annals of Internal Medicine.

[62]  J. Dillner,et al.  Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[63]  G. Hatemi,et al.  Infliximab does not suppress the tuberculin skin test (purified protein derivative). , 2007, The Journal of rheumatology.

[64]  Kimberly A. Reske,et al.  Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[65]  P. Rao,et al.  Pneumocystis carinii jiroveci pneumonia following infliximab infusion for Crohn disease: emphasis on prophylaxis. , 2007, Southern medical journal.

[66]  J. Bartlett,et al.  Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[67]  H. Goto,et al.  Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan. , 2007, World journal of gastroenterology.

[68]  E. Hoppenreijs,et al.  Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis , 2007, Annals of the rheumatic diseases.

[69]  C. Birbara,et al.  Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. , 2007, The Journal of rheumatology.

[70]  O. Lesur,et al.  Impact of Emergency Colectomy on Survival of Patients With Fulminant Clostridium difficile Colitis During an Epidemic Caused by a Hypervirulent Strain , 2007, Annals of surgery.

[71]  H. Ogata,et al.  Cytomegalovirus Is Frequently Reactivated and Disappears Without Antiviral Agents in Ulcerative Colitis Patients , 2007, The American Journal of Gastroenterology.

[72]  M. V. van Agtmael,et al.  Fatal Salmonella enteritidis septicaemia in a rheumatoid arthritis patient treated with a TNF-α antagonist , 2007, Scandinavian journal of infectious diseases.

[73]  S. Fischer,et al.  Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. , 2006, Blood.

[74]  Jan‐Åke Nilsson,et al.  Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. , 2006, Rheumatology.

[75]  J. Stockman.  Progressive Multifocal Leukoencephalopathy Complicating Treatment With Natalizumab and Interferon Beta-1a for Multiple Sclerosis , 2007 .

[76]  R. Owens.  Clostridium difficile-associated disease: changing epidemiology and implications for management. , 2007, Drugs.

[77]  R. Nelson,et al.  Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. , 2007, The Cochrane database of systematic reviews.

[78]  E. Kuijper,et al.  Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. , 2007, Journal of medical microbiology.

[79]  A. Rojiani,et al.  Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature , 2007, Bone Marrow Transplantation.

[80]  N. Cox,et al.  Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2007 , 2007 .

[81]  T. Mahl,et al.  Pneumocystis jiroveci (carinii) Pneumonia After Infliximab Therapy: A Review of 84 Cases , 2007, Digestive Diseases and Sciences.

[82]  J. Korzenik.  Is Crohn’s disease due to defective immunity? , 2006, Gut.

[83]  Herbert L DuPont,et al.  The practice of travel medicine: guidelines by the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[84]  B. Lashner,et al.  Cytomegalovirus Colitis Complicating Inflammatory Bowel Disease , 2006, The American Journal of Gastroenterology.

[85]  X. Mariette,et al.  Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalities. , 2006, European cytokine network.

[86]  Y. Zoellner,et al.  Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. , 2006, Vaccine.

[87]  F. Tubach,et al.  Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[88]  A. Giuliano,et al.  Prevalence of HPV infection among men: A systematic review of the literature. , 2006, The Journal of infectious diseases.

[89]  S. Mannor,et al.  Abnormalities of uterine cervix in women with inflammatory bowel disease. , 2006, World journal of gastroenterology.

[90]  L. Settas,et al.  Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[91]  R. Farah,et al.  Bacterial meningitis associated with infliximab , 2006, Pharmacy World and Science.

[92]  T. Iwaki,et al.  Myeloradiculitis caused by Cryptococcus neoformans infection in a patient with ulcerative colitis: A neuropathological study , 2006, Journal of the Neurological Sciences.

[93]  Christine H. Lee,et al.  Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[94]  A. Konstantinidou,et al.  Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease , 2006, Inflammatory bowel diseases.

[95]  N. Hyman,et al.  Herpes simplex virus colitis in ulcerative colitis, simulating malignancy , 2006, Histopathology.

[96]  S. Aslanidis,et al.  Inhibition of TNFα does not induce viral reactivation in patients with chronic hepatitis C infection: two cases , 2006, Clinical Rheumatology.

[97]  J. Bogousslavsky,et al.  Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[98]  R. Wallis,et al.  Tumor-necrosis-factor blockers: differential effects on mycobacterial immunity. , 2006, The Journal of infectious diseases.

[99]  Hyung Ok Kim,et al.  An atypical varicella exanthem associated with the use of infliximab , 2006, International journal of dermatology.

[100]  A. Silman,et al.  Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. , 2006, Arthritis and rheumatism.

[101]  M. Kim,et al.  Case report: lymphoma arising in an ileal pouch anal anastomosis after immunomodulatory therapy for inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[102]  I. Koralnik.  Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? , 2006, Annals of neurology.

[103]  M. Humbert,et al.  Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists , 2006, Arthritis research & therapy.

[104]  M. Peterson,et al.  Reactivation histoplasmosis after treatment with anti-tumor necrosis factor alpha in a patient from a nonendemic area. , 2006, Respiratory medicine.

[105]  I. Buchan,et al.  Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. , 2006, JAMA.

[106]  N. Weng.  Aging of the immune system: how much can the adaptive immune system adapt? , 2006, Immunity.

[107]  G. Pawelec,et al.  Aging and innate immunity. , 2006, Immunity.

[108]  M. Doğanay,et al.  Actinomycoses and Nocardia pulmonary infections , 2006, Current opinion in pulmonary medicine.

[109]  W. Sandborn,et al.  Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[110]  C. Wheeler,et al.  Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial , 2006, The Lancet.

[111]  M. Lehtinen,et al.  Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses , 2006, PLoS medicine.

[112]  L. Mcfarland.  Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease , 2006, The American Journal of Gastroenterology.

[113]  Mathias W Pletz,et al.  Impact of corticosteroids on the immune response to a MF59-adjuvanted influenza vaccine in elderly COPD-patients. , 2006, Vaccine.

[114]  F. Barkhof,et al.  Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. , 2006, The New England journal of medicine.

[115]  D. Weinstock,et al.  Preemptive diagnosis and treatment of Epstein–Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development , 2006, Bone Marrow Transplantation.

[116]  William D. Lees,et al.  Defective acute inflammation in Crohn's disease: a clinical investigation , 2006, The Lancet.

[117]  B F Warren,et al.  European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis , 2006, Gut.

[118]  W. Vogel,et al.  Subfulminant hepatitis B after infliximab in Crohn's disease: need for HBV-screening? , 2006, World journal of gastroenterology.

[119]  Sunenshine Rh,et al.  Clostridium difficile-associated disease: new challenges from an established pathogen. , 2006 .

[120]  P. Rutgeerts,et al.  Review article: infliximab therapy for inflammatory bowel disease – seven years on , 2006, Alimentary pharmacology & therapeutics.

[121]  J. Erlichman,et al.  Live virus immunization after orthotopic liver transplantation , 2006, Pediatric transplantation.

[122]  Frederick Wolfe,et al.  Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. , 2006, Arthritis and rheumatism.

[123]  N. Agnantis,et al.  Rectal Epstein-Barr virus-positive Hodgkin's lymphoma in a patient with Crohn's disease: Case report and review of the literature , 2006, Scandinavian journal of gastroenterology.

[124]  M. Bijl,et al.  Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease , 2005, Annals of the rheumatic diseases.

[125]  S. Targan,et al.  Patients with Inflammatory Bowel Disease are at Risk for Vaccine-Preventable Illnesses , 2005, The American Journal of Gastroenterology.

[126]  E. Mendelson,et al.  Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNFα blockers , 2005, Annals of the rheumatic diseases.

[127]  A. Verma.  Progressive Multifocal Leukoencephalopathy in a Patient Treated With Natalizumab , 2006 .

[128]  G. Lichtenstein.  Sargramostim for Active Crohn's Disease , 2006 .

[129]  G. Lichtenstein.  Progressive Multifocal Leukoencephalopathy After Natalizumab Therapy for Crohn's Disease , 2006 .

[130]  M. Iborra,et al.  Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn's disease. , 2006, Gut.

[131]  D. Tougeron,et al.  [Severe varicella infection during treatment with infliximab for Crohn's disease]. , 2006, Gastroenterologie clinique et biologique.

[132]  F. Aoki,et al.  The use of antiviral drugs for influenza: recommended guidelines for practitioners. , 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[133]  G. Jönsson,et al.  Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. , 2006, Rheumatology.

[134]  V Demicheli,et al.  Vaccines for measles, mumps and rubella in children. , 2013, The Cochrane database of systematic reviews.

[135]  L. Lambert,et al.  Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[136]  B. Metchock,et al.  Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[137]  J. Sany,et al.  Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab. , 2005, The Journal of rheumatology.

[138]  M. Pescovitz,et al.  Ganciclovir and Acyclovir Reduce the Risk of Post‐Transplant Lymphoproliferative Disorder in Renal Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[139]  Matthias Schneider,et al.  Infections in patients with rheumatoid arthritis treated with biologic agents. , 2005, Arthritis and rheumatism.

[140]  F. Derouin,et al.  Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study , 2005, Bone Marrow Transplantation.

[141]  D. Rampton.  Preventing TB in patients with Crohn’s disease needing infliximab or other anti-TNF therapy , 2005, Gut.

[142]  S. Franceschi,et al.  Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis , 2005, The Lancet.

[143]  M. Arias,et al.  [Brachial plexitis and myelitis and herpes-zoster lumbar plexus disorder in patient treated with infliximab]. , 2005, Neurologia.

[144]  J. Torre-Cisneros,et al.  Infliximab does not activate replication of lymphotropic herpesviruses in patients with refractory rheumatoid arthritis. , 2005, Rheumatology.

[145]  M. Kersten,et al.  [Epstein-Barr virus-related lymphomas in patients with inflammatory bowel disease]. , 2005, Nederlands tijdschrift voor geneeskunde.

[146]  F. Zoulim,et al.  Rheumatological manifestations of hepatitis C: incidence in a rheumatology and non-rheumatology setting and the effect of methotrexate and interferon. , 2005, Rheumatology.

[147]  M. Broder,et al.  Reactivation of latent granulomatous infections by infliximab. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[148]  Y. Yeh,et al.  Tuberculin reactivity in adults after 50 years of universal bacille Calmette-Guerin vaccination in Taiwan. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[149]  G. Lichtenstein,et al.  Methods to avoid infections in patients with inflammatory bowel disease. , 2005, Inflammatory bowel diseases.

[150]  Christopher Dye,et al.  Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. , 2005, JAMA.

[151]  J. Gómez-Reino,et al.  Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. , 2005, Arthritis and rheumatism.

[152]  Cosette M Wheeler,et al.  Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. , 2005, The Lancet. Oncology.

[153]  E. Hachulla,et al.  Opportunistic infections in polymyositis and dermatomyositis. , 2005, Arthritis and rheumatism.

[154]  S. Tsiodras,et al.  Septic arthritis due to Salmonella enteritidis associated with infliximab use , 2005, Scandinavian journal of infectious diseases.

[155]  B. Wang,et al.  Clinical infection with Strongyloides sterocoralis following etanercept use for rheumatoid arthritis. , 2005, Arthritis and rheumatism.

[156]  A. del Rosso,et al.  Pneumonitis caused by Legionella pneumoniae in a patient with rheumatoid arthritis treated with anti-TNF-alpha therapy (infliximab). , 2005, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[157]  D. Hopkins,et al.  Improving influenza, pneumococcal polysaccharide, and hepatitis B vaccination coverage among adults aged <65 years at high risk: a report on recommendations of the Task Force on Community Preventive Services. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[158]  N. Zein.  Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study. , 2005, Journal of hepatology.

[159]  I. T. Ten Berge,et al.  Clinical and Immunologic Aspects of Cytomegalovirus Infection in Solid Organ Transplant Recipients , 2005, Transplantation.

[160]  L. Beaugerie,et al.  Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery , 2005, Gut.

[161]  E. Puchhammer-Stöckl,et al.  Serum epstein–barr virus DNA load in primary epstein–barr virus infection , 2005, Journal of medical virology.

[162]  D. Jewell,et al.  Ciclosporin use in acute ulcerative colitis: a long-term experience , 2005, European journal of gastroenterology & hepatology.

[163]  Sophie Hambleton,et al.  Preventing Varicella-Zoster Disease , 2005, Clinical Microbiology Reviews.

[164]  H. Schlitt,et al.  Management of herpes simplex virus type 1 pneumonia following liver transplantation , 1996, Infection.

[165]  R. Stellini,et al.  Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease , 1995, Digestive Diseases and Sciences.

[166]  E. Bouza,et al.  Clinical manifestations, treatment and control of infections caused by Clostridium difficile. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[167]  ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 61, April 2005. Human papillomavirus. , 2005, Obstetrics and gynecology.

[168]  M. Hayney,et al.  Influenza Vaccine Antibody Responses in Lung Transplant Recipients , 2004 .

[169]  M. A. van de Laar,et al.  Disseminated primary varicella infection during infliximab treatment. , 2004, The Journal of rheumatology.

[170]  H. Lode,et al.  Immunogenity of the pneumococcal polysaccharide vaccine in COPD patients. The effect of systemic steroids. , 2004, Respiratory medicine.

[171]  T. Bush,et al.  Disseminated Primary Varicella after Initiation of Infliximab for Crohn's Disease , 2004, The American Journal of Gastroenterology.

[172]  U. Ghoshal,et al.  Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. , 2004, Journal of medical microbiology.

[173]  Y. Shiratori,et al.  Pneumocystis carinii pneumonia in patients with ulcerative colitis , 2004, Journal of Gastroenterology.

[174]  T. Mertens,et al.  Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[175]  L. Cohen,et al.  Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone , 2004, Canadian Medical Association Journal.

[176]  J. Reveille,et al.  Anti-tumor necrosis factor agents for rheumatoid arthritis in the setting of chronic hepatitis C infection. , 2004, Arthritis and rheumatism.

[177]  D. Vassilopoulos,et al.  Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection , 2004, Annals of the rheumatic diseases.

[178]  J. Leighton,et al.  The Diagnostic Yield of Stool Pathogen Studies During Relapses of Inflammatory Bowel Disease , 2004, Journal of clinical gastroenterology.

[179]  A. Gottlieb,et al.  Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases. , 2004, Journal of the American Academy of Dermatology.

[180]  María del Valle García-Sánchez,et al.  Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection. , 2004, Inflammatory bowel diseases.

[181]  B. Sands,et al.  Guidelines for immunizations in patients with inflammatory bowel disease. , 2004, Inflammatory bowel diseases.

[182]  H. P. McNeil,et al.  Disseminated Salmonella typhimurium infection secondary to infliximab treatment. , 2004, Arthritis and rheumatism.

[183]  J. Sanderson,et al.  Experience with the use of low-dose methotrexate for inflammatory bowel disease , 2004, European journal of gastroenterology & hepatology.

[184]  F. González‐Huix,et al.  Chronic hepatitis B reactivation following infliximab therapy in Crohn’s disease patients: need for primary prophylaxis , 2004, Gut.

[185]  D. Rampton,et al.  Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool , 2004, European journal of gastroenterology & hepatology.

[186]  C. Allaart,et al.  Cavitating pneumonia after treatment with infliximab and prednisone , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[187]  G. Niedobitek,et al.  Epstein–barr virus (EBV) infection and expression of the interleukin‐12 family member EBV‐induced gene 3 (EBI3) in chronic inflammatory bowel disease , 2004, Journal of medical virology.

[188]  R S Wallis,et al.  Granulomatous infectious diseases associated with tumor necrosis factor antagonists. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[189]  M. V. van Agtmael,et al.  A case of Legionellosis during treatment with a TNFα antagonist , 2004 .

[190]  T. Longacre,et al.  Cytomegalovirus Infection in Steroid-refractory Ulcerative Colitis: A Case-Control Study , 2004, The American journal of surgical pathology.

[191]  P. Rutgeerts,et al.  Long-term Outcome of Treatment with Intravenous Cyclosporin in Patients With Severe Ulcerative Colitis , 2004, Inflammatory bowel diseases.

[192]  J. Nicolas,et al.  Epstein-Barr Virus Viral Load in Crohn’s Disease: Effect of Immunosuppressive Therapy , 2004, Inflammatory bowel diseases.

[193]  R. Striker,et al.  EFFECT OF ANTIMETABOLITE IMMUNOSUPPRESSANTS ON FLAVIVIRIDAE, INCLUDING HEPATITIS C VIRUS , 2004, Transplantation.

[194]  J. Rubins,et al.  The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. , 2004, Seminars in arthritis and rheumatism.

[195]  R. Kurzrock,et al.  Epstein-Barr Virus and Cancer , 2004, Clinical Cancer Research.

[196]  John L. Johnson,et al.  A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis , 2004, AIDS.

[197]  A. Kinder,et al.  Severe herpes zoster after infliximab infusion , 2004, Postgraduate Medical Journal.

[198]  Kathleen A Snella,et al.  Listeria Meningitis Associated with Infliximab , 2004, The Annals of pharmacotherapy.

[199]  A. Zinsmeister,et al.  The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. , 2004, Gastroenterology.

[200]  R. Malekzadeh,et al.  Herpes simplex virus encephalistis during immunosuppressive treatment of ulcerative colitis. , 2004, MedGenMed : Medscape general medicine.

[201]  E. Oldfield.  Clostridium difficile-associated diarrhea: risk factors, diagnostic methods, and treatment. , 2004, Reviews in gastroenterological disorders.

[202]  T. Mahl,et al.  Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease. , 2004, Digestive diseases and sciences.

[203]  P. Geusens,et al.  High incidence of hepatotoxicity of isoniazid treatment for tuberculosis chemoprophylaxis in patients with rheumatoid arthritis treated with methotrexate or sulfasalazine and anti-tumour necrosis factor inhibitors , 2003, Annals of the rheumatic diseases.

[204]  J. Wester,et al.  Disseminated tuberculosis, pulmonary aspergillosis and cutaneous herpes simplex infection in a patient with infliximab and methotrexate , 2003, Intensive Care Medicine.

[205]  H. Dupont,et al.  Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[206]  M. Wener,et al.  Effect of tumour necrosis factor α antagonists on serum transaminases and viraemia in patients with rheumatoid arthritis and chronic hepatitis C infection , 2003, Annals of the rheumatic diseases.

[207]  M. Delmée,et al.  A European survey of diagnostic methods and testing protocols for Clostridium difficile. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[208]  M. Sherman,et al.  Seroprevalence of human papillomavirus-16, -18, -31, and -45 in a population-based cohort of 10 000 women in Costa Rica , 2003, British Journal of Cancer.

[209]  J. Lewis,et al.  Corticosteroids and immunomodulators: postoperative infectious complication risk in inflammatory bowel disease patients. , 2003, Gastroenterology.

[210]  Pilar Barrera,et al.  Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression. , 2003, Arthritis and rheumatism.

[211]  J. Goss,et al.  Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols , 2003, Clinical Microbiology Reviews.

[212]  S. Landolfo,et al.  The human cytomegalovirus. , 2003, Pharmacology & therapeutics.

[213]  M. Wilcox,et al.  Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. , 2003, The Journal of hospital infection.

[214]  E. Martı́n-Mola,et al.  Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Glück et al. , 2003, Arthritis and rheumatism.

[215]  J. Whang‐Peng,et al.  Steroid‐free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV‐carriers with lymphoma , 2003, Hepatology.

[216]  J. Deeks,et al.  Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak , 2003, The Lancet.

[217]  D. Hommes,et al.  Infliximab therapy in Crohn's disease: safety issues. , 2003, The Netherlands journal of medicine.

[218]  M. Lederman,et al.  A study of the immunology, virology, and safety of prednisone in HIV-1-infected subjects with CD4 cell counts of 200 to 700 mm(-3). , 2003, Journal of acquired immune deficiency syndromes.

[219]  G. Lichtenstein,et al.  Nutrition in Crohn disease , 2003, Current opinion in gastroenterology.

[220]  F. X. Bosch,et al.  Epidemiologic classification of human papillomavirus types associated with cervical cancer. , 2003, The New England journal of medicine.

[221]  M. Braun,et al.  Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. , 2003, Arthritis and rheumatism.

[222]  M. Manns,et al.  Acute CMV-Colitis in a Patient with a History of Ulcerative Colitis , 2003, Scandinavian journal of gastroenterology.

[223]  R. Baldassano,et al.  Safety and Steroid-Sparing Experience Using Infliximab for Crohn's Disease at a Pediatric Inflammatory Bowel Disease Center , 2003, American Journal of Gastroenterology.

[224]  Gillian D. Sanders,et al.  Cost Effectiveness of a Potential Vaccine for Human papillomavirus , 2003, Emerging infectious diseases.

[225]  M. Gassull,et al.  [Consensus guideline on tuberculosis and treatment of inflammatory bowel disease with infliximab. Spanish Working Group on Crohn Disease and Ulcerative Colitis]. , 2003, Gastroenterologia y hepatologia.

[226]  H. Tilg,et al.  A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. , 2003, Gut.

[227]  K. Wood,et al.  Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy. , 2003, American journal of respiratory and critical care medicine.

[228]  M. Lemyze,et al.  [Severe varicella zoster pneumonia during the course of treatment with azathioprine for Crohn's disease]. , 2003, Revue des maladies respiratoires.

[229]  G. Sarosi,et al.  Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy. , 2003, Chest.

[230]  K. Hosie,et al.  Perianal Hodgkin's lymphoma complicating Crohn's disease , 2003, International Journal of Colorectal Disease.

[231]  P. Hopewell,et al.  Clinical practice. Latent tuberculosis infection. , 2002, The New England journal of medicine.

[232]  D. Buskila,et al.  Specific antibody response after influenza immunization in systemic lupus erythematosus. , 2002, The Journal of rheumatology.

[233]  M. Greene,et al.  Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. , 2002, Arthritis and rheumatism.

[234]  Didier Pittet,et al.  Guideline for Hand Hygiene in Health-Care Settings Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC / SHEA / APIC / IDSA Hand Hygiene Task Force , 2002 .

[235]  J. Korzenik,et al.  Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor , 2002, The Lancet.

[236]  Karl-Heinz Krause,et al.  Ageing and infection. , 2002, The Lancet. Infectious diseases.

[237]  Jennifer S. Smith,et al.  Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. , 2002, The Journal of infectious diseases.

[238]  M. Braun,et al.  Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. , 2002, Arthritis and rheumatism.

[239]  S. Gabriel,et al.  Predictors of infection in rheumatoid arthritis. , 2002, Arthritis and rheumatism.

[240]  U. Müller-Ladner,et al.  Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. , 2002, Arthritis and rheumatism.

[241]  K. O’Rourke,et al.  Pneumocystis carinii pneumonia following a second infusion of infliximab. , 2002, Rheumatology.

[242]  S. Peckham,et al.  Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab. , 2002, The Journal of rheumatology.

[243]  G. Grell,et al.  Hyperinfective Strongyloidiasis in the Medical Ward: Review of 27 Cases in 5 Years , 2002, Southern medical journal.

[244]  Lynne V McFarland,et al.  Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease , 2002, American Journal of Gastroenterology.

[245]  K. Kain,et al.  Serology and eosinophil count in the diagnosis and management of strongyloidiasis in a non-endemic area. , 2002, The American journal of tropical medicine and hygiene.

[246]  R. Taplitz,et al.  Pneumonia caused by herpesviruses in recipients of hematopoietic cell transplants. , 2002, Seminars in respiratory infections.

[247]  E. Grimprel,et al.  Prevalence and Genetic Characterization of Toxin A Variant Strains of Clostridium difficile among Adults and Children with Diarrhea in France , 2002, Journal of Clinical Microbiology.

[248]  A. Stallmach,et al.  Role of Infections in the Manifestation or Reactivation of Inflammatory Bowel Diseases , 2002, Inflammatory bowel diseases.

[249]  J Lees,et al.  European framework for tuberculosis control and elimination in countries with a low incidence , 2002, European Respiratory Journal.

[250]  C. Sirio,et al.  Fulminant Clostridium difficile: An Underappreciated and Increasing Cause of Death and Complications , 2002, Annals of surgery.

[251]  E. Wing,et al.  Listeria monocytogenes: clinical and experimental update. , 2002, The Journal of infectious diseases.

[252]  K. Tashima,et al.  Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. , 2002, AIDS research and human retroviruses.

[253]  A. Zinsmeister,et al.  Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. , 2002, Gastroenterology.

[254]  A. Fillet.  Prophylaxis of Herpesvirus Infections in Immunocompetent and Immunocompromised Older Patients , 2002, Drugs & aging.

[255]  J. Mangino,et al.  Reactivation of histoplasmosis after treatment with infliximab. , 2002, The American journal of medicine.

[256]  Malbea A Lapete,et al.  Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .

[257]  F. Castelli,et al.  Epidemiology of travelers' diarrhea. , 2001, Journal of travel medicine.

[258]  P. Mazzone,et al.  The humoral immune response to influenza vaccination in lung transplant patients , 2001, European Respiratory Journal.

[259]  M. A. Ritz,et al.  Severe pneumococcal pneumonia following treatment with infliximab for Crohn's disease. , 2001, Inflammatory bowel diseases.

[260]  M. Loeb,et al.  Quinolone Use as a Risk Factor for Nosocomial Clostridium difficile-Associated Diarrhea , 2001, Infection Control &#x0026; Hospital Epidemiology.

[261]  R. Wiesner,et al.  Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. , 2001, Transplantation.

[262]  P. Okhuysen.  Traveler's diarrhea due to intestinal protozoa. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[263]  S. Targan,et al.  Outcome of cytomegalovirus infections in patients with inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[264]  D. Crawford,et al.  Biology and disease associations of Epstein-Barr virus. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[265]  R. M. Hendry,et al.  Immune response to influenza vaccine in adult liver transplant recipients , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[266]  M. Borowitz,et al.  Primary Epstein-Barr virus-associated Hodgkin disease of the ileum complicating Crohn disease. , 2001, Archives of pathology & laboratory medicine.

[267]  G. Pietrosi,et al.  Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis , 2001, American Journal of Gastroenterology.

[268]  V. Moreno,et al.  Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference , 2001, Journal of clinical pathology.

[269]  P. Reinke,et al.  RAPID DECLINE OF ANTIBODIES AFTER HEPATITIS A IMMUNIZATION IN LIVER AND RENAL TRANSPLANT RECIPIENTS , 2001, Transplantation.

[270]  S. Campbell,et al.  Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection. , 2001, European journal of gastroenterology & hepatology.

[271]  W. Sandborn,et al.  Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients , 2000, American Journal of Gastroenterology.

[272]  J. Keane,et al.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. , 2001, The New England journal of medicine.

[273]  M. Vergara,et al.  [Fulminant infection caused by varicella herpes zoster in patient with Crohn disease undergoing treatment with azathioprine]. , 2001, Gastroenterologia y hepatologia.

[274]  W. Yeo,et al.  Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: A prospective study of 626 patients with identification of risk factors , 2000, Journal of medical virology.

[275]  G. Triadafilopoulos,et al.  Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea , 2000, American Journal of Gastroenterology.

[276]  N. Muñoz,et al.  Human papillomavirus and cancer: the epidemiological evidence. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[277]  T. Leet,et al.  Environmental control to reduce transmission of Clostridium difficile. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[278]  M. Gershwin,et al.  Phenotypic and functional considerations in the evaluation of immunity in nutritionally compromised hosts. , 2000, The Journal of infectious diseases.

[279]  F. Cobelens,et al.  Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity , 2000, The Lancet.

[280]  M. Keighley,et al.  Risk factors for intra-abdominal sepsis after surgery in Crohn's disease , 2000, Diseases of the colon and rectum.

[281]  S. Castle,et al.  Clinical relevance of age-related immune dysfunction. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[282]  S. Goldberg,et al.  Hepatotoxicity Associated with Isoniazid Preventive Therapy: A 7-Year Survey from a Public Health Tuberculosis Clinic , 2000 .

[283]  F. Barbut,et al.  Epidemiology of Recurrences or Reinfections ofClostridium difficile-Associated Diarrhea , 2000, Journal of Clinical Microbiology.

[284]  J. Kovacs,et al.  Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. , 2000, The New England journal of medicine.

[285]  G. Rimmelzwaan,et al.  Efficacy of influenza vaccination in adult liver transplant recipients , 2000, Journal of medical virology.

[286]  F. Baldanti,et al.  High Levels of Epstein-Barr Virus DNA in Blood of Solid-Organ Transplant Recipients and Their Value in Predicting Posttransplant Lymphoproliferative Disorders , 2000, Journal of Clinical Microbiology.

[287]  F. Allerberger,et al.  Epstein-Barr virus-associated Hodgkin's lymphoma and legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A. , 2000, Human pathology.

[288]  J. Lewis.  Drug‐induced liver disease , 1990, The Medical clinics of North America.

[289]  丸澤 宏之.  Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen , 2000 .

[290]  F. Igea,et al.  [Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease]. , 2000 .

[291]  E. Jaffe,et al.  Epstein-Barr virus-positive primary gastrointestinal Hodgkin's disease: association with inflammatory bowel disease and immunosuppression. , 2000, The American journal of surgical pathology.

[292]  A. Garrido Serrano,et al.  [Fatal infectious mononucleosis during azathioprine treatment in Crohn's disease]. , 2000, Gastroenterologia y hepatologia.

[293]  F Y Aoki,et al.  Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. , 2000, Lancet.

[294]  K. H. Webb.  Prevalence of toxin A negative/B positive Clostridium difficile strains. , 2000, The Journal of hospital infection.

[295]  E. Vasiliauskas,et al.  Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. , 1999, Gastroenterology.

[296]  P. Pizzo,et al.  Fever in immunocompromised patients. , 1999, The New England journal of medicine.

[297]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[298]  A. Monto,et al.  Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections. , 1999, The Journal of infectious diseases.

[299]  Z. Younossi,et al.  Immunogenicity of hepatitis A vaccine in decompensated liver disease , 1999, American Journal of Gastroenterology.

[300]  I. Ojanguren,et al.  Cytomegalovirus infection in patients with inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[301]  B. Korelitz,et al.  Shingles during the course of treatment with 6-mercaptopurine for inflammatory bowel disease , 1999, American Journal of Gastroenterology.

[302]  D. Torre,et al.  Acyclovir for treatment of infectious mononucleosis: a meta-analysis. , 1999, Scandinavian journal of infectious diseases.

[303]  E. Díaz-Jouanen,et al.  Tuberculosis prophylaxis in patients with steroid treatment and systemic rheumatic diseases. A case-control study. , 1999, Clinical and experimental rheumatology.

[304]  G. Risi,et al.  Prevention of infection in the immunocompromised host. , 1998, American journal of infection control.

[305]  P. Poignard,et al.  Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient. , 1998, Transplantation.

[306]  S. Zielen,et al.  Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. , 1998, Transplantation.

[307]  B. Gazzard,et al.  Summary of the II International Symposium on Cytomegalovirus. , 1998, Antiviral research.

[308]  D. Thorley-Lawson,et al.  EBV persistence in memory B cells in vivo. , 1998, Immunity.

[309]  G E Bignardi,et al.  Risk factors for Clostridium difficile infection. , 1998, The Journal of hospital infection.

[310]  A. Svennerholm,et al.  Immune Responses in Ileostomy Fluid and Serum after Oral Cholera Vaccination of Patients Colectomized because of Ulcerative Colitis , 1998, Infection and Immunity.

[311]  R. Guerrant,et al.  Persistent diarrhea in the returned traveler. , 1998, Infectious disease clinics of North America.

[312]  K. Koike,et al.  Persistent viremia after recovery from self‐limited acute hepatitis B , 1998, Hepatology.

[313]  D. Gerding,et al.  Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[314]  G. Ternák,et al.  The serological signs of the Epstein-Barr virus (EBV) activity in the elderly. , 1997, Acta microbiologica et immunologica Hungarica.

[315]  D. Sachar,et al.  Management of varicella infection during the course of inflammatory bowel disease. , 1997, The American journal of gastroenterology.

[316]  B. Harms,et al.  Pneumocystis Carinii pneumonia postrestorative proctocolectomy for ulcerative colitis: A role for perioperative prophylaxis in the cyclosporine era? , 1997, Diseases of the colon and rectum.

[317]  N. LeLeiko,et al.  Disseminated nocardiosis complicating medical therapy in Crohn's disease. , 1997, Journal of pediatric gastroenterology and nutrition.

[318]  M. Kelly,et al.  Primary intestinal Hodgkin's disease complicating ileal Crohn's disease. , 1997, The Australian and New Zealand journal of surgery.

[319]  D. Thompson,et al.  Herpes zoster encephalomyelitis associated with low dose methotrexate for rheumatoid arthritis. , 1997, The Journal of rheumatology.

[320]  B. Hicks,et al.  Lesson of the week: cyclosporin treatment for ulcerative colitis complicated by fatal pneumocystis carinii pneumonia , 1997, BMJ.

[321]  H. Golden.  Herpes zoster encephalomyelitis in a patient with rheumatoid arthritis treated with low dose methotrexate. , 1997, The Journal of rheumatology.

[322]  M. Lederman,et al.  Cytokines and cytokine therapies in HIV infection. , 1997, AIDS clinical review.

[323]  R. Chandra.  Nutrition, immunity and infection: from basic knowledge of dietary manipulation of immune responses to practical application of ameliorating suffering and improving survival. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[324]  F. Chisari,et al.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.

[325]  J. Bartlett,et al.  Medical Management of HIV Infection , 1996 .

[326]  J. Lacy,et al.  Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[327]  G. Gerna,et al.  Diagnosis of human cytomegalovirus infections in the immunocompromised host. , 1996, Clinical and diagnostic virology.

[328]  U. Bode,et al.  Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women. , 1996, Gynecologic oncology.

[329]  H. El‐Serag,et al.  Fulminant herpes colitis in a patient with Crohn's disease. , 1996, Journal of clinical gastroenterology.

[330]  H. Dupont,et al.  Persistent diarrhea in travelers. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[331]  W. M. Lee,et al.  Drug-induced hepatotoxicity. , 1995, The New England journal of medicine.

[332]  H. Dombret,et al.  Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection. , 1995, The Journal of rheumatology.

[333]  S. Kraker,et al.  Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine. , 1995, Journal of pediatric gastroenterology and nutrition.

[334]  R. Westendorp,et al.  Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. , 1995, Gut.

[335]  D. Ching.  Severe, disseminated, life threatening herpes zoster infection in a patient with rheumatoid arthritis treated with methotrexate. , 1995, Annals of the rheumatic diseases.

[336]  E. Loftus,et al.  Cytomegalovirus as an exacerbating factor in ulcerative colitis. , 1994, Journal of clinical gastroenterology.

[337]  A. Teufel,et al.  Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine safety and immunogenicity. , 1994, The Journal of rheumatology.

[338]  A. van der Heide,et al.  Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. , 1994, Annals of the rheumatic diseases.

[339]  G. Bruyn,et al.  Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis. , 1994, Scandinavian journal of rheumatology.

[340]  R. Goodgame.  Gastrointestinal Cytomegalovirus Disease , 1993, Annals of Internal Medicine.

[341]  M. Iseman.  Treatment of multidrug-resistant tuberculosis. , 1993, The New England journal of medicine.

[342]  J. Casselman,et al.  Primary Hodgkin disease of the ileum complicating crohn disease , 1993, Cancer.

[343]  R. Whitley,et al.  ACYCLOVIR: A DECADE LATER , 1993 .

[344]  C. Bernstein,et al.  Pneumocystis carinii pneumonia in patients with ulcerative colitis treated with corticosteroids. , 1993, The American journal of gastroenterology.

[345]  I. Sartori.  The Self-limited Nature of Chronic Idiopathic Diarrhea: , 1993 .

[346]  H. Wolfsen,et al.  Fulminant herpes hepatitis mimicking hepatic abscesses. , 1993, Journal of clinical gastroenterology.

[347]  B. Debuono,et al.  Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[348]  R. Chandra.  RETRACTED: Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects , 1992, The Lancet.

[349]  R. Pounder,et al.  Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction , 1992, Journal of medical virology.

[350]  P. Jipp,et al.  [Herpes simplex-associated exacerbation of Crohn's disease. Successful treatment with acyclovir]. , 1992, Deutsche medizinische Wochenschrift.

[351]  M. Newkirk,et al.  Complications of immunosuppression associated with weekly low dose methotrexate. , 1991, The Journal of rheumatology.

[352]  R. P. Thompson,et al.  The influence of zinc status and malnutrition on immunological function in Crohn's disease. , 1991, Gastroenterology.

[353]  L. Moreland,et al.  Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate. , 1991, The American journal of medicine.

[354]  I. Rowe,et al.  Reiter's syndrome and associated arthritides. , 1991, Rheumatic diseases clinics of North America.

[355]  A. Lok,et al.  Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. , 1991 .

[356]  E. Bloemena,et al.  The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo , 1990, Clinical and experimental immunology.

[357]  A. Stuck,et al.  Risk of infectious complications in patients taking glucocorticosteroids. , 1989, Reviews of infectious diseases.

[358]  A. Fauci,et al.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[359]  J. Orloff,et al.  Toxic megacolon in cytomegalovirus colitis. , 1989, The American journal of gastroenterology.

[360]  E. Werner,et al.  Cell-mediated immunoreactivity in AIDS. , 1989, Immunology today.

[361]  J. Mcsherry.  Parasitology: diagnostic yield of stool examination. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[362]  H. Janowitz,et al.  Fulminant herpes simplex hepatitis in a patient with ulcerative colitis. , 1988, Gut.

[363]  T. Gross,et al.  Vaccine-associated poliomyelitis in a household contact with Netherton's syndrome receiving long-term steroid therapy. , 1987, The American journal of medicine.

[364]  R. Steffen,et al.  Health problems after travel to developing countries. , 1987, The Journal of infectious diseases.

[365]  R. Purcell,et al.  Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. , 1987, Gastroenterology.

[366]  B. Yvonnet,et al.  Age‐ and sex‐related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal) , 1987, Journal of medical virology.

[367]  W. Weimar,et al.  IMPAIRMENT OF THE IMMUNE RESPONSE TO INFLUENZA VACCINATION IN RENAL TRANSPLANT RECIPIENTS BY CYCLOSPORINE, BUT NOT AZATHIOPRINE , 1986, Transplantation.

[368]  G. Bodey,et al.  Infections of the gastrointestinal tract in the immunocompromised patient. , 1986, Annual review of medicine.

[369]  S. Targan,et al.  Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients. , 1985, Gastroenterology.

[370]  H. Cooper,et al.  Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease. , 1985, The American journal of gastroenterology.

[371]  D. Jewell,et al.  Yersinia colitis associated with Crohn's disease. , 1985, Postgraduate medical journal.

[372]  J. Armstrong,et al.  Antibody Response After Influenza Immunization in Renal Transplant Patients Receiving Cyclosporin A or Azathioprine , 1983, Infection and immunity.

[373]  W. Szmuness,et al.  Incidence of hepatitis B virus infections in preschool children in Taiwan. , 1982, The Journal of infectious diseases.

[374]  J. H. Shaw,et al.  Hodgkin's lymphoma: a complication of small bowel Crohn's disease. , 1982, The Australian and New Zealand journal of surgery.

[375]  M. Whittaker,et al.  A case of Hodgkin's disease complicating Crohn's disease. , 1982, Clinical oncology.

[376]  T. Berne,et al.  Response of Renal Allograft Recipients to Pneumococcal Vaccine , 1980, Annals of surgery.

[377]  John E. Bennett,et al.  Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .

[378]  R. Sheers,et al.  HODGKIN’S DISEASE AS A COMPLICATION OF CROHN’S DISEASE , 1978, The Medical journal of Australia.

[379]  M. Keighley,et al.  Hodgkin's disease complicating Crohn's colitis. , 1977, Surgery.

[380]  W. J. Collins.  Malignant lymphoma complicating regional enteritis. Case report and review of the literature. , 1977, The American journal of gastroenterology.

[381]  S. Truelove,et al.  Intensive intravenous regimen for membranous colitis. , 1976, British medical journal.

[382]  R. Beasley,et al.  Vertical transmission of hepatitis B antigen in Taiwan. , 1975, The New England journal of medicine.

[383]  J. Kapsenberg.  [The varicella-zoster virus]. , 1967, Nederlands tijdschrift voor geneeskunde.

[384]  S. Powell,et al.  Ulcerative post-dysenteric colitis. , 1966, Gut.

[385]  W. Symmers.  OPPORTUNISTIC INFECTIONS. THE CONCEPT OF 'OPPORTUNISTIC INFECTIONS'. , 1965, Proceedings of the Royal Society of Medicine.